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ABSTRACT 
The first reversed phase high performance liquid chromatographic method for quantitation studies  of, Praziquantel and Pyrantel Pamoate has 
been developed and validated to be a simple, sensitive, rapid, specific, precise, and accurate method. Chromatographic separation was achieved 
on C18 column (250×4.6 mm-5μm p.s). Methanol and water in a ratio [85:15 v/v] as a mobile phase at flow rate of 0.8ml/min. UV detection was 
operated at 217 nm and injection volum was 20 μl.. The proposed method showed good linearity, accuracy, precision and was successfully 
applied for determination of the drugs in laboratory prepared pharmaceutical dosage forms. The current method has been statistically 
validated according to the ICH guidelines and this method has been subsequently developed and applied successfully to determine the levels of 
Praziquantel and Pyrantel pamoate in a combined formulation and in the routine quality control analysis with good accuracy and sensitivity. 
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INTRODUCTION 
The high performance liquid chromatography of 
praziquantel and pyrantel pamoate in tablet dosage forms of 
total .1  Helmint infections which are influceneed by parasites 
,affect more than one billion people in the world .owing to 
the narrow spectrum of  antihelmintic drugs it is needed to 
use combination chemotheraphy to control mixed infections. 
are the most common treatments of helmint infections 
.Another drug combination ,which is the theme of our work 
,consists of oxantel pamoate ,pyrantel pamoate  and 
praziquantel and notably is being used to treat dogs . 
determined  praziquantel by using C18 column at 217 nm 
after solid phase extraction for preparing the sample . 
enatiomers of praziquantel in human plasma were separated 
by Liu and Stewart by using cellulose –based chrial column 
and Vu detrctor.  Binary mixture and combined preparation 
of similar antihelmintic drugs as mebendazole,fenbendazole 
,albendazole and their related impurities determined 
together .2   Helminthiases are parasitic diseases commonly 
found in pets and cause significant morbidity in dogs and 
cats.These infections are promoted mainly for nematodes 
,cestodes and trematodes and have public health significance 
because parasitic diseases also transmissible to humans 3 
 
Fig1: Structure of Praziquantel 
Pyrantel pamoate is an orally administered veterinary 
anthelmintic that is effective  against a variety of round 
worms and hook worms in dogs ,cats ,horses ,birds and 
rabbits .It also used to treat pin worms in humans 
mechanism of action is drug exerts its action as a 
depolarizing blocking agent that particularly affords spastic 
paralysis in susceptible helminatic  4  This has  the result of 
causing thr worm to lose its grip on the intestinal wall and be  
passed out of the system by natural  process .since pyrantel 
is poorly absorbed by the hosts  is unaffected by the small 
dosage of medication used . Spastic (tetanic) paralyzing 
agents. In particular pyrantel pamoate , may induce complete 
intestinal obstruction in heavy worm load. Giardia is a 
cosmopolitan parasite colonises the small intestine of 
domestic animals,inciuding liverstock ,dogs and cats .Giardia 
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is also a parasite of humans and wildlife ,due to the zoonotic 
risk to humans,it is very important to identify and treat 
giardiasis in dogs and  cats 5 
 
Fig2: Structure of Pyrantel pamoate 
MATERIAL AND METHOD  
List of Instruments  
Table 1: List of apparatus/ instruments used. 
Sr no Name Modele 
1 Weighing balance PGB 100 
2 Ultra-Sonicator WUC-4L 
3 
UV- Spectrophotometer 
and Software 
UV2450 UV probe v 2.3.3 
4 HPLC HPLC 3000 series 
                                         
List of Chemicals 
Table 2: List of chemical used Preparation of mobile 
phase 
Sr. No Reagents and Chemicals Details 
1 Methanol HPLC grade 
2 Water HPLC grade 
3 Phosphoric acid HPLC grade 
4 Praziquantel Veko Care pvt.Ltd 
 Pytantel Pamoate Veko Care pvt.Ltd 
 
Mixed a HPLC grade Methanol: ortho phosphoric acid Buffer 
10mM (80:20)in volumetric flask. Filter through  
undervaccum filtration. 
Preparation Stock Solution:  
Procedure: 
Accurately weighed quantity of Praziquantel and 
Pyrantelpamoate 10 mg individually dissolved in 10 ml 
volumetric flask using mobile phase and solution was 
sonicated for 20 minutes and volume is make up to the mark 
to get 1000 μg/ml and  filtered through 0.45μm membrane 
filter. 
Preparation of Sample solution: 
Procedure: 
 20 tablets were weighed and powdered, tablets powder 
equivalent to 10 mg of Praziquantel and Pyrantelpamoate 
was transferred 100 ml volumetric flask, sufficient amount of 
mobile phase was added and dissolved by 20minutes 
ultrasonication. then made the volume up to the mark with 
the mobile phase and filtered with 0.45µ filter paper. Pipette 
out  from above solution and diluted to 10 ml mobile phase 
and use for sample injection  
Selection of analytical wavelength:  
Accurately weighed quantity of Praziquantel and 
Pyrantelpamoate 10 mg dissolved in 100 ml volumetric flask 
and volume is make up to the mark to get 100 μg/ml.. 
Solution was scanned using UV-Visible Spectrophotometer in 
the spectrum mode between the wavelength ranges of 400 
nm to 200 nm. The wavelength selected was 217 nm.
 
 
Fig. 3.Wavelength of Praziquantel and Pyrantelpamoate 
 
Optimized chromatographic condition  
In the present study the separation of Praziquantel and 
Pyrantel pamoate was achieved by using  column cosmosil 
C18, (250×4.6mm,5µ)with mobile phase consisting of 
mixture of methanol and water in the ratio of 85:15 at a flow 
rate 0.8 ml/min with uv detection wavelength of 217nm at 
ambient temperature. The run time for praziquantel and 
pyrantel pamoate found to be 6.59min respectively.
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Figure No. 3. Chromatogram for sample solution. 
Name of drug Time Area Resolution Th. Plate Asymmetry 
Praziquantel 3.618   1155711 6.56 7736 1.25      
Pyrantelpamoate 5.066 1263705 0.00   6916   1.18       
 
 
Figure  No. 5. Chromatogram for standard solution. 
Name RT(min) Area Resolution 
Theoretical 
plate 
Asymmetry 
factor 
Praziquantel 3.631 879928 6.57    7612 1.31        
Pyrantelpamoate 5.080    980190 0.00      7143 1.17        
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Validation of the Developed Method: 
A. Linearity: 
Linearity of an analytical method is its ability to elicit test 
results that are directly proportional to the concentration of 
analyte in samples within a given range.The linearity of the 
analytical method is determined by mathematical treatment 
of test results obtained by analysis of samples with analyte 
concentrations across the claimed range. Area plotted 
graphically as a function of analyte concentration. 
Percentage curve fittings are calculated.  
 
Table 4: Result of linearity 
SI.NO. Linearity Level 
 
        Praziquantel  Pyrentel Pamoate 
  Conc.(µg / ml ) Peak Area Conc.(µg / ml ) Peak Area 
1 Level-1          10 184335          10 215539 
2 Level-2          20 406014          20 444221 
3 Level-3          30 649335          30 714782 
4 Level-4          40 886149          40 982534 
5 Level-5          50 1149364          50 1256928 
Linearity Range  1.30 -8.5 19.25 -116.4 
Slope                    18861.4                  21741.7 
R2                    0.999                  0.998 
 
 
Fig.No. 6.Linearity graph for Praziquantel 
 
 
Fig.No. 7.Linearity graph for Pyrantel pamoate.
B. ACCURACY 
The accuracy of an analytical method is the closeness of 
test results obtained by that method to the true value. 
Accuracy may often the expressed as percent recovery 
by the assay of known added amounts of analyte 
according to USP guidelines.The accuracy of an 
analytical method is determined by applying the 
method to analyzed samples, to which known amounts 
of analyte have been added. The accuracy is calculated 
from the test results as the percentage of analyte 
recovered by the assay. 
 
Table 5: Recovery Studies for Praziquantel   and Pyrantel Pamoate 
Drug Accuracy level  Area of Standard Area of Sample % Recovery 
     
Praziquantel 
50 705248 825248 105.2 
100 979423 1029423 108.2 
150 1305721 13957215 106.3 
Pyrantel pamoate 
50 645948 707095 109.4662419 
        100 879928 980190 111.3943414 
        150 1155711 1263705 109.3443776 
          
 
C. Robustness: 
The robustness of an analytical method is determined by 
analysis of aliquots from homogenous lots by differing 
physical parameters that may differ but are still within the 
specified parameters of the assay. The sample along with 
standard was injected under different chromatographic 
conditions as shown below 
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Table 6: Robustness Result Data 
Sr.no  Conc    Peak area Peak Area 
Praziquantel Pyrantel Pamoate 
1 25 406014 406014 
2 25 405186 409524 
3 25 405945 407079 
Mean 405715 407539 
Standard  Deviation      459.42 1799.65 
% RSD  0.1132 0.4415 
 
Precision: Precision of the method was studied as 
repeatability and intermediate precision .Repeatability was 
determined by system or instrumental and method precision 
(intra assay precision).  System precision studies were 
performed by injecting six repeated injection of 100 % 
concentration from standard solution within a day.  Peak 
area and % RSD were calculated. Method precision studies 
were performed and three replicates were obtained. The % 
RSD values are found to be within the limits. 
Intermediate Precision: The intermediate precision of the 
method was checked by intra –day  and intra –day study and  
results
Table 7: Method Precision Results for Praziquantel and Pyrantel Pamoate 
                                                  
Replicates 
Peak  Area    Con c .Obtained  (µg /ml ) 
Praziquantel Pyrantel Pamoate Praziquantel  Pyrantel Pamoate 
1 646865 748447 9.745 9.845 
2 648675 718447 9.643 9.96 
3 650465 713625 10.4 10.12 
Mean 647268 715386 9.89 9.99 
                       Standard   Deviation 0.2839 0.2936 
                      % RSD 1.68 1.24 
 
Table 9 Inter –Day  Precission  Results for  Praziquantel and Pyrantel Pamoate 
Replicate 
 
Date 
Interval 
Praziquantel Pyrantel Pamoate 
Peak Area Conc. Peak Area Conc. 
1 Day 1 651713 9.84 715732 9.97 
2 Day 2 647268 9.93 719485 9.94 
3 Day 3 642754 9.78 712931 9.98 
Mean 9.83  9.96 
Standard  deviation 0.246  0.178 
% RSD 1.60  0.30 
 
CONCLUSION 
The proposed Quantitation studies and validation method 
was found to be simple, precise, accurate and rapid  for the 
determination  of Praziquantel and Pyrantel pamoate. The 
coefficient of correlation was obtained in acceptable range 
.The percentage recovery obtained in acceptable range 
.variation in flow rate, wavelength, does not have any effect 
on the % RSD of standard and assay value.The relative 
standard deviation of main peak area ,tailing factor and 
therotical plate  is well within the acceptable range . Hence 
the precision of given method is confirmed. Thus from the 
above result of the individual method is conclude that the 
analytical method is validated and found to be satisfactory. 
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